October 10, 1997
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
RE: Rule 24f-2 Notice for
EV Traditional Worldwide Health Sciences Fund, Inc.
1933 Act File No. 2-95103
1940 Act File No. 811-4196
In accordance with the provisions of Rule 24f-2 under the Investment
Company Act of 1940, EV Traditional Worldwide Health Sciences Fund, Inc. (the
"Fund") hereby files its Rule 24f-2 Notice for the fiscal year ended August 31,
1997 ("Fiscal Year"). It is the intent of the Fund to cease operations
effective August 31, 1997, therefore this notice serves to terminate the Fund's
election under Rule 24f-2.
No shares of the Fund which have been registered under the Securities Act
of 1933 (other than pursuant to Rule 24f-2) remained unsold at the beginning of
the Fiscal Year.
3,479,728 shares of the Fund, with an aggregate sales price of
$50,014,627, were sold during the Fiscal Year in reliance upon the Declaration
of the Trust pursuant to Rule 24f-2 which registered an indefinite amount of
securities. Attached to this Rule 24f-2 Notice, and made part hereof, is an
opinion of counsel indicating that the securities, the registration of which
the Notice makes definite in number, were legally issued, fully paid, and non-
assessable by the Fund.
274,867 shares of the Fund, with an aggregate sales price of $3,802,439,
were issued during the Fiscal Year in connection with the Fund's dividend
reinvestment plan.
For the Fiscal Year, the Fund sold an aggregate of 3,754,595 shares,
including those issued pursuant to its dividend reinvestment plan, with an
aggregate sales price of $53,817,066.
1,900,964 shares of the Fund, with an aggregate value of $26,562,560, were
redeemed during the Fiscal Year.
In accordance with subsection (c) of Rule 24f-2, $8,258.94 has been wired
to the SEC account at Mellon Bank, which represents the registration fee. Such
fee is based upon the actual aggregate sale price for which such securities
were sold during the Fiscal Year, including dividend reinvestments, reduced by
the actual aggregate redemption price of the shares redeemed by the Fund during
the Fiscal Year.
Rule 24f-2 Notice for Page 2
EV Traditional Worldwide Health Sciences Fund, Inc.
1933 Act File No. 2-95103
1940 Act File No. 811-4196
Aggregate Sale Price for Shares
Sold During Fiscal Year Pursuant to
Rule 24f-2 $ 50,014,627
Aggregate Price of Shares Issued
During Fiscal Year In Connection
with its Dividend Reinvestment Plan 3,802,439
Aggregate Price of Shares Sold $ 53,817,066
Reduced by the Difference Between
(1) Aggregate Redemption Price of
Shares Redeemed During the
Fiscal Period 26,562,560
and
(2) Aggregate Redemption Price of
Redeemed Shares Previously
Applied by Fund Pursuant to
Rule 24e-2(a) in Filings Made
Pursuant to Section 24(e)(1) of
Investment Company Act of 1940 0
Equals $ 27,254,506
Any questions regarding the matter should by addressed to Jim Thebado, Eaton
Vance Management, 24 Federal Street, Boston, Massachusetts 02110.
Sincerely,
Barbara E. Campbell
Assistant Treasurer
Enclosure (Opinion of Counsel)
October 10, 1997
OPINION OF COUNSEL
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
RE: Rule 24f-2 Notice for
EV Traditional Worldwide Health Sciences Fund, Inc.
1933 Act File No. 2-95103
1940 Act File No. 811-4196
Gentlemen:
By filing the captioned Notice pursuant to Rule 24f-2 under the Investment
Company Act of 1940, as amended, the Fund made definite the registration under
the Securities Act of 1933 of 3,754,595 shares sold, including those sold
pursuant to its dividend reinvestment plan, in reliance upon said Rule 24f-2
during the fiscal year ended August 31, 1997.
It is the opinion of the undersigned that such shares were legally issued,
fully paid and nonassessable.
Sincerely,
Eric G. Woodbury,
Vice President
Member of Massachusetts Bar
